NEW YORK--(BUSINESS WIRE)--BTIG announced today that it will host its annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Tuesday, February 11 through Wednesday ...

BTIG analyst Mark Massaro notes that earlier today, a short report was published on GeneDx (WGS), which alleges wholesale reimbursement fraud at the company. Shares were down about 4%, and BTIG ...

BTIG notes that Bloomberg reported earlier that Buy-rated Paysafe (PSFE) is exploring a sale after receiving takeover interest. The article says the company is also exploring the disposal of non ...

In a report released today, Vincent Caintic from BTIG maintained a Buy rating on Enova International (ENVA – Research Report), with a price target of $129.00. The company’s shares closed ...

To schedule a one-on-one meeting with Mr. Goldberger, investors are encouraged out to their BTIG representative or contact the electroCore investor relations team at investors@electrocore.com.

In a report released today, Sam Eiber from BTIG reiterated a Buy rating on InMode (INMD – Research Report), with a price target of $25.00. The company’s shares opened today at $17.20.

“This partnership addresses the growing demand among institutional traders for advanced, centralised technology that enables seamless access to deep liquidity and high-quality execution,” said the ...

BTIG analyst Andrew Harte lowered the firm’s price target on Lightspeed (LSPD) to $17 from $21 and keeps a Buy rating on the shares. The shares are selling off following the fiscal Q3 results ...

In a report released today, Marie Thibault from BTIG reiterated a Buy rating on Haemonetics (HAE – Research Report), with a price target of $105.00. The company’s shares opened today at $64.00.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price target of $122.00. The company’s shares opened ...

BTIG analyst Marie Thibault maintained a Buy rating on Boston Scientific (BSX – Research Report) today and set a price target of $120.00. The company’s shares opened today at $102.94. Leverage ...